Quantifying the possible cross-reactivity risk of an HPV16 vaccine.
- Published in:
- Journal of Experimental Therapeutics & Oncology, 2009, v. 8, n. 1, p. 65
- By:
- Publication type:
- Article
Works in Journal of Experimental Therapeutics & Oncology, 2009, Vol 8, Issue 1
Results: 7
1
2
Chimeric antigen receptors for stem cell based immunotherapy.
- Published in:
- Journal of Experimental Therapeutics & Oncology, 2009, v. 8, n. 1, p. 53
- By:
- Publication type:
- Article
3
Human ABC transporter ABCG2 in cancer chemotherapy and pharmacogenomics.
- Published in:
- Journal of Experimental Therapeutics & Oncology, 2009, v. 8, n. 1, p. 5
- By:
- Publication type:
- Article
4
Alleviating effect of active hexose correlated compound (AHCC) for anticancer drug-induced side effects in non-tumor-bearing mice.
- Published in:
- Journal of Experimental Therapeutics & Oncology, 2009, v. 8, n. 1, p. 43
- By:
- Publication type:
- Article
5
Single fraction spine radiosurgery for myeloma epidural spinal cord compression.
- Published in:
- Journal of Experimental Therapeutics & Oncology, 2009, v. 8, n. 1, p. 35
- By:
- Publication type:
- Article
6
Takashi Tsuruo (1943-2008).
- Published in:
- 2009
- By:
- Publication type:
- Obituary
7
Resveratrol downregulates PI3K/Akt/mTOR signaling pathways in human U251 glioma cells.
- Published in:
- Journal of Experimental Therapeutics & Oncology, 2009, v. 8, n. 1, p. 25
- By:
- Publication type:
- Article